MedPath

Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis

Completed
Conditions
Brain Metastases, Adult
Registration Number
NCT05095766
Lead Sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Male or female over 18 years of age;<br><br> - Having undergone gamma knife radiosurgery for brain metastasis;<br><br> - Presenting for a first MRI follow-up (Cohort C1);<br><br> - Presence of one or more brain metastases with increased enhancement on follow-up MRI<br> (Cohort C2.1 and C2.2); A participant recruited for Cohort C1 could be recruited for<br> follow-up in Cohort C2.1 or C2.2 if the MRI result is ambiguous.<br><br>Exclusion Criteria:<br><br> - Pregnancy or breastfeeding;<br><br> - Other condition that may influence the imaging result;<br><br> - Renal impairment (<30 mL/min/1.73 m2). This threshold is consistent with recent RAC<br> recommendations; Note: For participants with intermediate renal clearance (30-60<br> mL/min/1.73 m2), the total gadobutrol dose injected is set at the manufacturer's<br> recommended clinical dose. For patients with renal clearance greater than 60<br> mL/min/1.73 m2, a dose of 1.5x the normal dose is used. These dose values have been<br> approved by Dr. Chénard and are consistent with the RAC recommendations.<br><br> - Inability to maintain supine position for the required duration (variable, depending<br> on the sequence);<br><br> - Patients who have previously received full brain irradiation;<br><br> - Patients who are claustrophobic and cannot tolerate insertion into the MRI scanner;

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of novel MRI method with current MRI exam method;Comparison of DCE-MRI method with FET PET
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath